Skip to main content
. Author manuscript; available in PMC: 2006 Jan 25.
Published in final edited form as: Pharmacogenet Genomics. 2005 Apr;15(4):245–256. doi: 10.1097/01213011-200504000-00008

Table 2.

Primers used for allele-specific and SSCP genotyping

Primera Description Sequence (5′ to 3′)b
Exon 3: g.7,700_7,702dupGAC polymorphism (p.71Ddup)
hF2–44 wild-type forward AGA AAT GTC CTG TTT CAG TGc CT
hF2–45 71Ddup forward gcc ccg ggg gCA Aga AAA TGT CCT GTT TCA GTc ACG
hF2–46r common reverse TTA TGC AGG AAG TTT GG
Exon 4: g.10,951delG polymorphism (p.V113fs)
hF2–83 common forward TTC AAG ACA ACT GTC CTT A
hF2–49r common reverse AAC CAT AAC TGC GTC AAA G
Exon 5: g.13,732C > T polymorphism (p.S195L)
hF2–50 wild-type forward ggg ggg ggg ggc CCT caT GAT TGG AAT GGG AAC cTC
hF2–79 S195L forward CTG GTG ATT GGt ATG GGA AAg TT
hF2–52r common reverse TGA GCA GCA TTC TTA CTC AG
Exon 8: g.22,060T > G polymorphism (p.N413 K)
hF2–59 common forward TTG TGT AGC CTG CCC TCA GA
hF2–60r wild-type reverse ccc ccc ccc cgt GGT CAA TTC TTT TgT CA
hF2–61r N413 K reverse CAc GTC AAT TCT TTT TaC C
Exon 9: g.23,238C > T polymorphism (p.Q472X)
hF2–42 FMO2*1 forward CGG ACC CTG CAA CTC CTt TC
hF2–20 FMO2*2 forward caa gct tat aTA TTT CGG ACC CTG CAA gTC CTA TTc
hF2–18r Common reverse caa agc TTA TGC TGA CTA GGc
a

Lower case ‘r’ indicates a reverse primer, while absence of an ‘r’ indicates a forward primer.

b

Lower case indicates intentional sequence mismatches; bold/underlining indicates the polymorphism discriminating nucleotide.

c

These primers have been described previously [16].